Why is Biofil Chemicals falling/rising?

As of 06-Aug, Biofil Chemicals & Pharmaceuticals Ltd's stock price is currently at 44.00, reflecting a decrease of 0.8, or 1.79%. The stock has recently outperformed its sector by 0.27%, but it has fallen after two consecutive days of gains. In terms of returns, the stock has seen a decline of 5.78% over the past month and a significant drop of 22.81% year-to-date. Additionally, while the stock is currently higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
Broader Market Context: The broader market context shows that the Sensex has declined by 1.15% over the past week, indicating that Biofil's short-term performance is relatively better than the benchmark. However, the pharmaceutical and drugs sector has experienced a drop of 2.17%, which may contribute to the stock's overall decline. Despite the recent increase in investor participation, as evidenced by a 2.34% rise in delivery volume, the stock's year-to-date performance remains significantly negative compared to the Sensex, which has gained 3.08% in the same period.